Your browser doesn't support javascript.
loading
Risk factors for treatment failure after allogeneic transplantation of patients with CLL: a report from the European Society for Blood and Marrow Transplantation.
Schetelig, J; de Wreede, L C; van Gelder, M; Andersen, N S; Moreno, C; Vitek, A; Karas, M; Michallet, M; Machaczka, M; Gramatzki, M; Beelen, D; Finke, J; Delgado, J; Volin, L; Passweg, J; Dreger, P; Henseler, A; van Biezen, A; Bornhäuser, M; Schönland, S O; Kröger, N.
Affiliation
  • Schetelig J; Medical Department I, University Hospital, Technische Universität Dresden, Dresden, Germany.
  • de Wreede LC; Clinical Trials Unit, DKMS, gemeinnützige GmbH, Tübingen, Germany.
  • van Gelder M; Clinical Trials Unit, DKMS, gemeinnützige GmbH, Tübingen, Germany.
  • Andersen NS; Department Medical Statistics & Bioinformatics, Leiden University Medical Center, Leiden, The Netherlands.
  • Moreno C; Department of Internal Medicine, Division of Hematology, University Medical Center Maastricht, The Netherlands.
  • Vitek A; BMT Unit, Department of Hematology, Rigshospitalet, Copenhagen, Denmark.
  • Karas M; Hematologia, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
  • Michallet M; Department of Hematology, Institute of Hematology and Blood Transfusion, Prague, Czech Republic.
  • Machaczka M; Department of Hematology/Oncology, Charles University Hospital, Pilsen, Czech Republic.
  • Gramatzki M; Hématologie, Center Hospitalier Lyon-Sud, Lyon, France.
  • Beelen D; Department of Medicine at Huddinge, Hematology Center Karolinska and Karolinska Institutet, Stockholm, Sweden.
  • Finke J; Division of Stem Cell Transplantation and Immunotherapy, University Hospital Schleswig-Holstein, Kiel, Germany.
  • Delgado J; Department of Bone Marrow Transplantation, University Hospital, Essen, Germany.
  • Volin L; Department of Medicine-Hematology, University of Freiburg, Oncology, Freiburg, Germany.
  • Passweg J; Department of Hematology, Hospital Clinic, Institute of Hematology & Oncology, Barcelona, Spain.
  • Dreger P; Stem Cell Transplantation Unit, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland.
  • Henseler A; Department for Hematology, University Hospital, Basel, Switzerland.
  • van Biezen A; Medizinische Klinik und Poliklinik V, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany.
  • Bornhäuser M; Department Medical Statistics & Bioinformatics, Leiden University Medical Center, Leiden, The Netherlands.
  • Schönland SO; Department Medical Statistics & Bioinformatics, Leiden University Medical Center, Leiden, The Netherlands.
  • Kröger N; Medical Department I, University Hospital, Technische Universität Dresden, Dresden, Germany.
Bone Marrow Transplant ; 52(4): 552-560, 2017 Apr.
Article in En | MEDLINE | ID: mdl-28112746
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Lymphocytic, Chronic, B-Cell / Hematopoietic Stem Cell Transplantation Type of study: Clinical_trials / Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Bone Marrow Transplant Journal subject: TRANSPLANTE Year: 2017 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Lymphocytic, Chronic, B-Cell / Hematopoietic Stem Cell Transplantation Type of study: Clinical_trials / Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Bone Marrow Transplant Journal subject: TRANSPLANTE Year: 2017 Document type: Article Affiliation country: